Jeffrey Edwin Lee

Jeffrey Edwin Lee's AcademicInfluence.com Rankings

Jeffrey Edwin Lee

Biology

#9596

World Rank

#12820

Historical Rank

Computational Biology

#187

World Rank

#188

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Jeffrey Edwin Lee Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jeffrey Edwin Lee's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genomic Classification of Cutaneous Melanoma (2015) (2143)
B cells and tertiary lymphoid structures promote immunotherapy response (2020) (1046)
Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy (2006) (762)
Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. (2008) (730)
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. (2008) (699)
Pancreaticoduodenectomy with vascular resection: margin status and survival duration (2004) (545)
Impact of Resection Status on Pattern of Failure and Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma (2007) (538)
Detectable clonal mosaicism from birth to old age and its relationship to cancer (2012) (514)
Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma (2018) (500)
Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. (2003) (490)
Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma (2009) (449)
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. (2008) (444)
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators (2012) (444)
Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. (2006) (377)
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. (2018) (377)
Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients (2012) (352)
Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration (2001) (336)
Effect of Preoperative Biliary Decompression on Pancreaticoduodenectomy-Associated Morbidity in 300 Consecutive Patients (2001) (302)
Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study (2017) (302)
Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. (2011) (296)
Ethnic differences among patients with cutaneous melanoma. (2006) (291)
Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients. (2003) (278)
RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. (2005) (273)
Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer (2003) (265)
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression. (2011) (263)
Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma (2009) (255)
Genome-wide association study identifies three new melanoma susceptibility loci (2011) (252)
Antibiotic Treatment of Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue: An Uncontrolled Trial (1999) (249)
Role for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Thick (≥4 mm) Primary Melanoma (2000) (246)
Adrenal cortical carcinoma (2001) (230)
Parathyroid carcinoma: A 22‐year experience (2004) (223)
Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. (2003) (217)
Laparoscopic resection of adrenal cortical carcinoma: a cautionary note. (2005) (213)
Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. (2006) (207)
Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. (2008) (204)
Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma (2012) (204)
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma (2015) (199)
Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020. (2006) (197)
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. (2011) (196)
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. (2018) (193)
Revised American Joint Committee on Cancer Staging Criteria Accurately Predict Sentinel Lymph Node Positivity in Clinically Node-Negative Melanoma Patients (2003) (193)
Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome. (2002) (190)
Cost and Utilization Impact of a Clinical Pathway for Patients Undergoing Pancreaticoduodenectomy (2000) (185)
The learning curve in pancreatic surgery. (2007) (181)
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response (2021) (181)
Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography. (2008) (178)
Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head* (1996) (175)
Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival (2013) (174)
Invasive Squamous Cell Carcinoma of the Skin: Defining a High-Risk Group (2006) (168)
Predictors and Natural History of In-Transit Melanoma After Sentinel Lymphadenectomy (2004) (162)
The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors (2020) (160)
Perineural and Intraneural Invasion in Posttherapy Pancreaticoduodenectomy Specimens Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma (2012) (146)
Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3 (2011) (146)
Prospective Assessment of Postoperative Complications and Associated Costs Following Inguinal Lymph Node Dissection (ILND) in Melanoma Patients (2010) (145)
Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. (2003) (144)
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. (2014) (144)
Management of Pancreatic Endocrine Tumors in Multiple Endocrine Neoplasia Type 1 (2006) (142)
Intraductal Papillary Mucinous Neoplasms of the Pancreas: Effect of Invasion and Pancreatic Margin Status on Recurrence and Survival (2006) (135)
Surgical margins and prognostic factors in patients with thick (>4 mm) primary melanoma (1998) (135)
Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation (2010) (132)
Robot assisted transaxillary surgery (RATS) for the removal of thyroid and parathyroid glands. (2011) (131)
Recurrence of Adrenal Cortical Carcinoma Following Resection: Surgery Alone Can Achieve Results Equal to Surgery Plus Mitotane (2009) (131)
Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma. (2002) (131)
Major vascular resection as part of pancreaticoduodenectomy for cancer: Radiologic, intraoperative, and pathologic analysis (1999) (129)
The learning curve in pancreatic surgery (DOI: 10.1016/j.surg.2006.09.013) (2007) (125)
Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience (2016) (122)
Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer (2015) (122)
Surgical management of hereditary pheochromocytoma. (2004) (120)
The Need for Standardized Pathologic Staging of Pancreaticoduodenectomy Specimens (1996) (120)
A variant in FTO shows association with melanoma risk not due to BMI (2013) (120)
Genotype-phenotype analysis in multiple endocrine neoplasia type 1. (2002) (119)
Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy? (2007) (118)
Carcinoid tumors of the duodenum. (2005) (115)
Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma (2006) (114)
Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans. (2013) (111)
Ninety-day Postoperative Mortality Is a Legitimate Measure of Hepatopancreatobiliary Surgical Quality (2015) (106)
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma (2017) (105)
Surgeon symptoms, strain, and selections: Systematic review and meta-analysis of surgical ergonomics (2018) (104)
The Effect on Melanoma Risk of Genes Previously Associated With Telomere Length (2014) (103)
Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. (2009) (102)
Radiographic Tumor–Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer (2014) (101)
Adjuvant irradiation for axillary metastases from malignant melanoma. (2001) (98)
Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis. (2012) (98)
Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. (2004) (97)
Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic Cancer (2011) (96)
Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma. (2011) (95)
Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma (2006) (95)
Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma? (2013) (94)
Pancreaticoduodenectomy after placement of endobiliary metal stents (2005) (93)
Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. (2005) (91)
EUS-FNA for Pancreatic Neuroendocrine Tumors: A Tertiary Cancer Center Experience (2012) (90)
Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. (2005) (90)
Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer (2015) (89)
Polymorphisms in the DNA Repair Genes XPC, XPD, and XPG and Risk of Cutaneous Melanoma: a Case-Control Analysis (2006) (88)
Genome-wide association meta-analyses combining multiple risk phenotypes provides insights into the genetic architecture of cutaneous melanoma susceptibility (2020) (87)
Assessment of Prognostic Circulating Tumor Cells in a Phase III Trial of Adjuvant Immunotherapy After Complete Resection of Stage IV Melanoma (2012) (86)
PGC-1 coactivators regulate MITF and the tanning response. (2013) (86)
Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma. (2006) (84)
Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. (2012) (84)
Genetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma. (2006) (82)
Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1. (2005) (82)
Biochemotherapy in patients with metastatic anorectal mucosal melanoma (2004) (82)
Combined-modality therapy for patients with regional nodal metastases from melanoma. (2006) (82)
Venous resection in pancreatic cancer surgery. (2006) (81)
A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma. (2013) (81)
Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy (2012) (80)
Failure to Recognize Multiple Endocrine Neoplasia 2B: More Common Than We Think? (2007) (80)
Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy. (2012) (80)
Posterior Retroperitoneoscopic Adrenalectomy: Preferred Technique for Removal of Benign Tumors and Isolated Metastases (2008) (80)
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases (2017) (79)
Significance of Multiple Nodal Basin Drainage in Truncal Melanoma Patients Undergoing Sentinel Lymph Node Biopsy (2000) (79)
Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for Survival (2016) (78)
Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck (2004) (78)
Anatomy of the Superior Mesenteric Vein With Special Reference to the Surgical Management of First-order Branch Involvement at Pancreaticoduodenectomy (2008) (78)
Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. (2020) (77)
Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome (2018) (77)
Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma. (2011) (76)
Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma. (2007) (76)
Association of the Affordable Care Act Medicaid Expansion With Access to and Quality of Care for Surgical Conditions (2018) (76)
Long-term outcomes of surgical treatment for hereditary pheochromocytoma. (2013) (76)
Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism. (2009) (76)
Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients. (2003) (75)
Post‐therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation (2012) (75)
Melanoma adrenal metastasis: natural history and surgical management. (2008) (74)
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma (2017) (72)
Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma (2019) (70)
Open Pancreaticoduodenectomy Case Volume Predicts Outcome of Laparoscopic Approach: A Population-based Analysis (2016) (69)
Pheochromocytoma: advances in genetics, diagnosis, localization, and treatment. (2007) (68)
Selective Reoperation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic Resection (2012) (68)
C-reactive protein as a marker of melanoma progression. (2015) (67)
Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial? (2008) (66)
A Randomized Controlled Trial of Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-controlled Analgesia After Major Hepatopancreatobiliary Surgery (2017) (65)
Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation (2012) (64)
The Cost-Effectiveness of Neoadjuvant Chemoradiation is Superior to a Surgery-First Approach in the Treatment of Pancreatic Head Adenocarcinoma (2013) (64)
Surgical treatment of non‐functioning pancreatic islet cell tumors (2005) (64)
In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. (2005) (64)
Home-Based Exercise Prehabilitation During Preoperative Treatment for Pancreatic Cancer Is Associated With Improvement in Physical Function and Quality of Life (2019) (64)
RET fusion as a novel driver of medullary thyroid carcinoma. (2015) (63)
Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma. (2007) (61)
A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma (2018) (60)
Robot-Assisted Transaxillary Thyroid Surgery in the United States: Is it Comparable to Open Thyroid Lobectomy? (2012) (59)
Posterior retroperitoneoscopic adrenalectomy: a contemporary American experience. (2011) (59)
Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein. (2016) (58)
DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma. (2002) (58)
Radiographic and Serologic Predictors of Pathologic Major Response to Preoperative Therapy for Pancreatic Cancer. (2019) (57)
Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: A randomized controlled trial (NCT00506311) (2008) (57)
Pelvic Lymph Node Dissection Is Beneficial in Subsets of Patients with Node-positive Melanoma (2007) (56)
Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy (2017) (56)
PET/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: evaluation of the additive value after conventional imaging. (2012) (56)
Retroperitoneal dissection in patients with borderline resectable pancreatic cancer: operative principles and techniques. (2012) (55)
A Critical Assessment of Adjuvant Radiotherapy for Inguinal Lymph Node Metastases from Melanoma (2004) (55)
p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma. (2003) (55)
Frequency and Intensity of Postoperative Surveillance After Curative Treatment of Pancreatic Cancer: A Cost-Effectiveness Analysis (2013) (55)
Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas (2016) (55)
Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma (2017) (54)
Polymorphisms of Nucleotide Excision Repair Genes Predict Melanoma Survival (2012) (54)
Home-based exercise during preoperative therapy for pancreatic cancer (2017) (53)
Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk. (2011) (53)
Posterior retroperitoneoscopic adrenalectomy. (2009) (52)
Active Surveillance for Adverse Events Within 90 Days: The Standard for Reporting Surgical Outcomes After Pancreatectomy (2015) (51)
Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-γ (2015) (51)
Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review (2012) (51)
Genetic variants and haplotypes of the caspase‐8 and caspase‐10 genes contribute to susceptibility to cutaneous melanoma (2008) (51)
Fear of Cancer Recurrence after Curative Pancreatectomy: A Cross-sectional Study in Survivors of Pancreatic and Periampullary Tumors (2012) (51)
Adrenal ganglioneuroma: features and outcomes of 27 cases at a referral cancer centre (2014) (50)
Predictable criteria for selective, rather than routine, calcium supplementation following thyroidectomy. (2012) (50)
Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma (2015) (49)
Impact of Clinical and Pathologic Features on Tumor-Infiltrating Lymphocyte Expansion from Surgically Excised Melanoma Metastases for Adoptive T-cell Therapy (2011) (49)
Clinical calculator of conditional survival estimates for resected and unresected survivors of pancreatic cancer. (2012) (49)
Indications for operative intervention in patients with asymptomatic primary hyperparathyroidism: practice patterns of endocrine surgery. (2006) (48)
Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted Analysis (2019) (48)
Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness (2017) (47)
Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma (2010) (46)
Routine pre-operative ultrasonography for papillary thyroid cancer: effects on cervical recurrence. (2009) (46)
Tumor Invasion of Muscular Vessels Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma Who Have Received Neoadjuvant Therapy and Pancreaticoduodenectomy (2012) (45)
Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma (2006) (45)
Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma. (2009) (45)
Mapping FACT-melanoma quality-of-life scores to EQ-5D health utility weights. (2011) (45)
Is Surveillance Imaging Effective for Detecting Surgically Treatable Recurrences in Patients With Melanoma? A Comparative Analysis of Stage-Specific Surveillance Strategies (2014) (44)
Comprehensive Complication Index Predicts Cancer-specific Survival After Resection of Colorectal Metastases Independent of RAS Mutational Status (2017) (44)
Regional Nodal basin control is not compromised by previous sentinel lymph node biopsy in patients with melanoma (2000) (44)
Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection. (2012) (44)
Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma (2016) (44)
Identification of a melanoma susceptibility locus and somatic mutation in TET2. (2014) (43)
The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy (2016) (42)
Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism. (2007) (42)
Do No Harm, Except to Ourselves? A Survey of Symptoms and Injuries in Oncologic Surgeons and Pilot Study of an Intraoperative Ergonomic Intervention. (2017) (41)
Association between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes. (2017) (41)
Surgical Resection of Synchronously Metastatic Adrenocortical Cancer (2014) (41)
Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma (2013) (40)
Physical activity and exercise during preoperative pancreatic cancer treatment (2018) (40)
Abdominal Visceral Lesions in von Hippel-Lindau Disease: Incidence and Clinical Behavior of Pancreatic and Adrenal Lesions at a Single Center (2006) (40)
Borderline Resectable Adrenal Cortical Carcinoma: A Potential Role for Preoperative Chemotherapy (2014) (40)
Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy (2017) (39)
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality (2016) (39)
Operative and short-term oncologic outcomes of laparoscopic versus open liver resection for colorectal liver metastases located in the posterosuperior liver: a propensity score matching analysis (2018) (39)
The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy (2015) (39)
Morbidity and Mortality after Pancreaticoduodenectomy in Patients with Borderline Resectable Type C Clinical Classification (2013) (39)
Improving the yield of preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression. (2002) (38)
Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow‐up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients (2016) (38)
Impact and timing of bilateral adrenalectomy for refractory adrenocorticotropic hormone-dependent Cushing’s syndrome. (2013) (37)
Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature. (2016) (37)
Borderline Resectable Pancreatic Cancer: What Have We Learned and Where Do We Go From Here? (2011) (37)
Joint Effect of Multiple Common SNPs Predicts Melanoma Susceptibility (2013) (36)
Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer. (2014) (35)
Parathyroidectomy Improves Functional Capacity in “Asymptomatic” Older Patients With Primary Hyperparathyroidism: A Randomized Control Trial (2010) (35)
Adrenal Metastectomy is Safe in Selected Patients (2014) (35)
Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases (2018) (34)
Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine Tumors (2016) (34)
The biopsy-proven benign thyroid nodule: is long-term follow-up necessary? (2013) (34)
Current Approaches and Future Strategies for Pancreatic Carcinoma (2000) (34)
Differentiating Atypical Parathyroid Neoplasm from Parathyroid Cancer (2016) (34)
Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations. (2014) (33)
Remnant Liver Ischemia as a Prognostic Factor for Cancer-Specific Survival After Resection of Colorectal Liver Metastases (2017) (33)
Polymorphisms of TP53 Arg72Pro, but not p73 G4C14>A4TA4 and p21 Ser31Arg, contribute to risk of cutaneous melanoma. (2008) (33)
Clinical Features, Treatments, and Outcomes of Patients with Thymic Carcinoids and Multiple Endocrine Neoplasia Type 1 Syndrome at MD Anderson Cancer Center (2016) (33)
Validation of American Joint Committee on Cancer eighth staging system for gallbladder cancer and its lymphadenectomy guidelines. (2018) (33)
Mitochondrial DNA Copy Number in Peripheral Blood and Melanoma Risk (2015) (33)
Robotic-Assisted Retroperitoneoscopic Adrenalectomy: Making a Good Procedure Even Better (2013) (33)
Significance of Plasma Cytokine Levels in Melanoma Patients With Histologically Negative Sentinel Lymph Nodes (2001) (33)
Risk‐stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomy (2018) (33)
Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important. (2011) (32)
Educating Surgical Oncology Providers on Perioperative Opioid Use: Results of a Departmental Survey on Perceptions of Opioid Needs and Prescribing Habits (2019) (32)
Conditional Survival Estimates Improve Over 5 Years for Melanoma Survivors with Node-Positive Disease (2010) (32)
Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and Pancreatoduodenectomy (2018) (32)
Association of the diversity and composition of the gut microbiome with responses and survival (PFS) in metastatic melanoma (MM) patients (pts) on anti-PD-1 therapy. (2017) (31)
Current status of adjuvant therapy for pancreatic cancer. (2010) (31)
After Pancreatectomy, the “90 Days from Surgery” Definition Is Superior to the “30 Days from Discharge” Definition for Capture of Clinically Relevant Readmissions (2015) (31)
Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13,771 NSQIP patients. (2014) (31)
Outcomes and economic analysis of routine preoperative 4-dimensional CT for surgical intervention in de novo primary hyperparathyroidism: does clinical benefit justify the cost? (2012) (31)
Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer (2014) (30)
Pancreatic intraepithelial neoplasia and histological changes in non‐neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma (2013) (30)
Selective Perioperative Administration of Pasireotide is More Cost-Effective Than Routine Administration for Pancreatic Fistula Prophylaxis (2017) (30)
Outpatient minimally invasive parathyroidectomy is safe for elderly patients. (2009) (30)
Comprehensive Genomic Characterization of Parathyroid Cancer Identifies Novel Candidate Driver Mutations and Core Pathways (2018) (30)
Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A? (2010) (30)
Endoscopic Management of Duodenal Adenomas in Familial Adenomatous Polyposis—A Single-Center Experience (2012) (29)
Incidental Gallbladder Cancer: Residual Cancer Discovered at Oncologic Extended Resection Determines Outcome: A Report from High- and Low-Incidence Countries (2017) (29)
Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma. (2016) (29)
Randomized Controlled Trial of a Sun Protection Intervention for Children of Melanoma Survivors (2013) (29)
Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy. (2012) (29)
Circulating Tumor Cells and Early Relapse in Node-positive Melanoma (2020) (29)
Prognostic Scoring System to Risk Stratify Parathyroid Carcinoma. (2017) (29)
Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy (2008) (28)
Streamlining variability in hospital charges for standard thyroidectomy: Developing a strategy to decrease waste. (2014) (28)
Genetic variants in Fanconi Anemia Pathway Genes BRCA2 and FANCA Predict Melanoma Survival (2014) (28)
Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma (2019) (28)
Multimodality therapy offers a chance for cure in patients with pancreatic adenocarcinoma deemed unresectable at first operative exploration. (2012) (28)
Gamma probe identification of normal parathyroid glands during central neck surgery can facilitate parathyroid preservation. (2008) (28)
Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater (2017) (27)
Obesity-related genetic variants, human pigmentation, and risk of melanoma (2013) (27)
Impact of pancreatectomy on long‐term patient‐reported symptoms and quality of life in recurrence‐free survivors of pancreatic and periampullary neoplasms (2017) (27)
A High Positive Lymph Node Ratio is Associated with Distant Recurrence after Surgical Resection of Ampullary Carcinoma (2012) (27)
Followup of patients with papillary thyroid cancer: in search of the optimal algorithm. (2007) (27)
Advances in hepatectomy technique: Toward zero transfusions in the modern era of liver surgery. (2016) (27)
The Role of Thyroidectomy in Metastatic Disease to the Thyroid Gland (2014) (27)
Survival and Quality of Life of Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Interferon-Based Chemoradiation: A Phase II Trial (2011) (27)
Multidisciplinary management strategy for incidental cystic lesions of the pancreas. (2010) (27)
Race Does Not Impact Pancreatic Cancer Treatment and Survival in an Equal Access Federal Health Care System (2013) (27)
Common Locations of Parathyroid Adenomas (2011) (26)
Virtual Interviews for Surgical Training Program Applicants During COVID-19: Lessons Learned and Recommendations. (2020) (26)
Exonuclease 1 (EXO1) gene variation and melanoma risk. (2012) (26)
Cost effectiveness of adjuvant interferon in node-positive melanoma. (2007) (26)
Operative Failure in Minimally Invasive Parathyroidectomy Utilizing an Intraoperative Parathyroid Hormone Assay (2014) (26)
Component-wise gradient boosting and false discovery control in survival analysis with high-dimensional covariates (2015) (25)
Loss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases☆ (2019) (25)
Posterior Retroperitoneoscopic Adrenalectomy is a Safe and Effective Alternative to Transabdominal Laparoscopic Adrenalectomy for Pheochromocytoma (2011) (25)
Overexpression of Protein Phosphatase 4 Correlates with Poor Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma (2012) (25)
Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine Tumors (2015) (25)
Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center (2019) (25)
Oncologic progress for the treatment of parathyroid carcinoma is needed (2016) (25)
Risks of Hypoparathyroidism After Total Thyroidectomy in Children: A 21-Year Experience in a High-Volume Cancer Center (2020) (25)
Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma (2018) (25)
The role of genetics in the surgical management of familial endocrinopathy syndromes. (2003) (24)
Genotype‐phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: A 23‐year experience at a single institution (2018) (24)
Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer (2016) (24)
Viability of Cryopreserved Parathyroid Tissue: When Is Continued Storage versus Disposal Indicated? (2008) (24)
Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma (2018) (24)
Preexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosis (2016) (23)
Polymorphisms of the neuronal and inducible nitric oxide synthase genes and the risk of cutaneous melanoma (2007) (23)
Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma (2017) (23)
Presence of the human leukocyte antigen class II geneDRB1*1101 predicts interferon γ levels and disease recurrence in melanoma patients (2002) (22)
Extended Lymphadenectomy Is Required for Incidental Gallbladder Cancer Independent of Cystic Duct Lymph Node Status (2017) (22)
Clinical Factors Associated With Practice Variation in Discharge Opioid Prescriptions After Pancreatectomy. (2018) (21)
Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma. (2013) (20)
Gene Variants in Angiogenesis and Lymphangiogenesis and Cutaneous Melanoma Progression (2013) (20)
Musical preference correlates closely to professional roles and specialties in operating room: A multicenter cross-sectional cohort study with 672 participants. (2016) (20)
Functional Variants in Notch Pathway Genes NCOR2, NCSTN, and MAML2 Predict Survival of Patients with Cutaneous Melanoma (2015) (20)
The fallen one: the inferior parathyroid gland that descends into the mediastinum. (2009) (20)
Laparoscopic Glissonean Pedicle Transection (Takasaki) for Negative Fluorescent Counterstaining of Segment 6 (2017) (20)
Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach (2020) (19)
Outpatient virtual clinical encounters after complex surgery for cancer: a prospective pilot study of "TeleDischarge". (2016) (19)
Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma. (2020) (19)
Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression (2012) (19)
Reoperative parathyroidectomy: location of missed glands based on a contemporary nomenclature system. (2010) (19)
Early postoperative drain fluid amylase in risk-stratified patients promotes tailored post-pancreatectomy drain management and potential for accelerated discharge. (2019) (19)
Measuring the extent of total thyroidectomy for differentiated thyroid carcinoma using radioactive iodine imaging: relationship with serum thyroglobulin and clinical outcomes. (2014) (18)
Incidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors. (2019) (18)
Role of immune response, inflammation and tumor immune response-related cytokines/chemokines in melanoma progression. (2019) (18)
Vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Patency rates and outcomes associated with thrombosis (2018) (18)
On the Interplay of Telomeres, Nevi and the Risk of Melanoma (2012) (18)
Enhancing surgical performance by adopting expert musicians' practice and performance strategies (2018) (18)
Adenocarcinoma of the pancreas: recent controversies, current management, and future therapies (1996) (18)
Complication rates of resident-performed cataract surgery: Impact of early introduction of cataract surgery training. (2018) (18)
Comment and perspective on Sewnath and colleagues' recent meta-analysis of the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. (2003) (18)
Surgical management of thyroid carcinoma. (2005) (18)
No Association between Parkinson Disease Alleles and the Risk of Melanoma (2011) (17)
Correlates of Sun Protection and Sunburn in Children of Melanoma Survivors. (2016) (17)
Fewer adverse events after reoperative parathyroidectomy associated with initial minimally invasive parathyroidectomy. (2014) (17)
CLASSIFICATION OF LILIES USING RANDOM AMPLIFIED POLYMORPHIC DNA (RAPD) ANALYSIS (1996) (17)
Operative intervention for primary hyperparathyroidism offers greater bone recovery in patients with sporadic disease than in those with multiple endocrine neoplasia type 1–related hyperparathyroidism (2017) (17)
The expression of PTEN is associated with improved prognosis in patients with ampullary adenocarcinoma after pancreaticoduodenectomy. (2013) (16)
Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencing. (2018) (16)
Inverse Relationship between Vitiligo-Related Genes and Skin Cancer Risk. (2018) (16)
Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma. (2011) (15)
Virtual Interviews for Surgical Training Program Applicants During COVID-19: Lessons Learned and Recommendations (2020) (15)
The learning curve in pancreatic surgery. (2007) (15)
Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms (2019) (15)
Effective Laparoscopic Management Lymph Node Dissection for Gallbladder Cancer (2017) (14)
Postoperative local-regional radiation therapy in the treatment of parathyroid carcinoma: The MD Anderson experience of 35 years. (2017) (14)
Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-γ. (2015) (14)
Solid pseudopapillary neoplasm of the pancreas with prominent atypical multinucleated giant tumour cells (2013) (14)
The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinoma. (2019) (14)
Natural history and prognostic factors for localised small bowel adenocarcinoma (2020) (14)
Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival. (2021) (14)
Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival (2018) (13)
Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death‐ligand 1 expression and the presence of tumor‐infiltrating lymphocytes and macrophages (2018) (13)
Diagnostic performance of 18-F-FDG-PET–CT in adrenal lesions using histopathology as reference standard (2017) (13)
Integrated pathway and epistasis analysis reveals interactive effect of genetic variants at TERF1 and AFAP1L2 loci on melanoma risk (2015) (13)
Minimally Invasive Surgery for Primary and Metastatic Adrenal Malignancy. (2019) (13)
Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection (2019) (12)
Computed Tomography–Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer (2019) (12)
Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma (2021) (12)
Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma After Early Failure of FOLFIRINOX. (2019) (12)
Preoperative chemoradiation for adenocarcinoma of the pancreas: M.D. Anderson experience (1995) (12)
Laparoscopic Management of Gallbladder Cancer: A Stepwise Approach (2016) (12)
Operation duration and adrenal gland size, but not BMI, are correlated with complication rate for posterior retroperitoneoscopic adrenalectomy for benign diseases (2019) (12)
The Sequential Radiographic Effects of Preoperative Chemotherapy and (Chemo)Radiation on Tumor Anatomy in Patients with Localized Pancreatic Cancer (2020) (12)
Inpatient Opioid Use After Pancreatectomy: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients (2019) (12)
Diagnostic performance of adrenal CT in the differentiation of adenoma and pheochromocytoma (2019) (12)
Supports and Barriers to Home-Based Physical Activity During Preoperative Treatment of Pancreatic Cancer: A Mixed-Methods Study. (2019) (12)
Fear of cancer recurrence and quality of life among survivors of pancreatic and periampullary neoplasms. (2012) (11)
All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients (2017) (11)
Reviewing the review: a qualitative assessment of the peer review process in surgical journals (2018) (11)
Potential role for intraoperative gamma probe identification of normal parathyroid glands. (2003) (11)
Advances in Genetics, Diagnosis, Localization, and Treatment (2007) (11)
Educating surgical oncology providers on perioperative opioid use: A departmental survey 1 year after the intervention (2020) (11)
Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma (2018) (11)
Genetic Variants in WNT2B and BTRC Predict Melanoma Survival. (2017) (10)
Anatomic Resection Is Not Required for Colorectal Liver Metastases with RAS Mutation (2020) (10)
Association between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma risk. (2013) (10)
Is estrogen exposure a protective factor for pancreatic neuroendocrine tumours in female patients with multiple endocrine neoplasia syndrome type 1? (2017) (10)
Conceptual framework of middle hepatic vein anatomy as a roadmap for safe right hepatectomy. (2019) (10)
Opioid-Prescribing Practices After Oncologic Surgery: Opportunities for Improvement and a Call to Action. (2020) (10)
Preoperative gemcitabine (gem) and bevacizumab (bev)-based chemoradiation for resectable pancreatic adenocarcinoma (2008) (10)
Adrenocortical carcinoma. (2006) (10)
Utility of Intermediate-Delay Washout CT Images for Differentiation of Malignant and Benign Adrenal Lesions: A Multivariate Analysis. (2018) (10)
Risk-Stratified Pancreatectomy Clinical Pathway Implementation and Delayed Gastric Emptying (2020) (9)
Association of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and Outcomes (2015) (9)
Identification of DRG-1 As a Melanoma-Associated Antigen Recognized by CD4+ Th1 Cells (2015) (9)
Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma‐specific survival (2017) (9)
Genetic variants in ELOVL2 and HSD17B12 predict melanoma‐specific survival (2019) (9)
Phase II study of preoperation mFOLFIRINOX and chemoradiation for high-risk resectable and borderline resectable pancreatic adenocarcinoma. (2015) (9)
Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases (2021) (9)
From scalpel to console: a suggested model for surgical skill acquisition. (2010) (9)
Genetic variants in PDSS1 and SLC16A6 of the ketone body metabolic pathway predict cutaneous melanoma‐specific survival (2020) (9)
A toll-like receptor agonist to drive melanoma regression as a vaccination adjuvant or by direct tumor application. (2017) (9)
Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal Cancer. (2021) (9)
Sustained reduction in discharge opioid volumes through provider education: Results of 1168 cancer surgery patients over 2 years (2021) (9)
Reoperative surgery: a critical risk factor for complications inadequately captured by operative reporting and coding of lysis of adhesions. (2014) (9)
Combining Washout and Noncontrast Data From Adrenal Protocol CT: Improving Diagnostic Performance. (2018) (9)
Natural and orthogonal model for estimating gene–gene interactions applied to cutaneous melanoma (2013) (8)
Circulating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma. (2019) (8)
Pre-operative ultrasound identification of thyroiditis helps predict the need for thyroid hormone replacement after thyroid lobectomy. (2013) (8)
Loss of DPC4/SMAD4 expression in primary gastrointestinal neuroendocrine tumors is associated with cancer‐related death after resection (2017) (8)
Evaluation of Src Tyr419 as a predictive biomarker in a neoadjuvant trial using dasatinib in resectable malignant pleural mesothelioma. (2010) (8)
Total Transthoracic Approach Facilitates Laparoscopic Hepatic Resection in Patients with Significant Prior Abdominal Surgery (2017) (8)
Expression of Epithelial-Mesenchymal Transition Markers in Treated Pancreatic Ductal Adenocarcinoma. (2019) (8)
Contemporary analysis of complications associated with biliary stents during neoadjuvant therapy for pancreatic adenocarcinoma. (2019) (8)
Positive cystic duct margin at index cholecystectomy in incidental gallbladder cancer is an important negative prognosticator. (2019) (8)
Outcome of trimodality-eligible esophagogastric cancer (EC) patients who declined surgery after preoperative chemoradiation. (2012) (7)
First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma (2018) (7)
Impact of Intraoperative Dexamethasone on Surgical and Oncologic Outcomes for Patients with Resected Pancreatic Ductal Adenocarcinoma (2020) (7)
Cap-fitted endoscopic mucosal resection of ≥ 20 mm colon flat lesions followed by argon plasma coagulation results in a low adenoma recurrence rate (2020) (7)
Systemic gene therapy with tumor suppressor FUS1-nanoparticles for recurrent/metastatic lung cancer. (2010) (7)
Pathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal Adenocarcinoma (2017) (7)
Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resection. (2019) (7)
Functional annotation of melanoma risk loci identifies novel susceptibility genes. (2019) (7)
Generation of Monoclonal Antibody MS17-57 Targeting Secreted Alkaline Phosphatase Ectopically Expressed on the Surface of Gastrointestinal Cancer Cells (2013) (7)
Factors Influencing Exercise Following Pancreatic Tumor Resection (2020) (7)
Genetic variants in the calcium signaling pathway genes are associated with cutaneous melanoma-specific survival (2018) (6)
Preliminary whole-exome sequencing reveals mutations that imply common tumorigenicity pathways in multiple endocrine neoplasia type 1 patients. (2014) (6)
Novel Genetic Variants of ALG6 and GALNTL4 of the Glycosylation Pathway Predict Cutaneous Melanoma-Specific Survival (2020) (6)
Quality of endoscopy reporting at index colonoscopy significantly impacts outcome of subsequent EMR in patients with > 20 mm colon polyps (2019) (6)
Preoperative Chemoradiation for Borderline Resectable Pancreatic Cancer: The New Standard? (2018) (6)
Differentiation of Malignant and Benign Adrenal Lesions With Delayed CT: Multivariate Analysis and Predictive Models. (2018) (6)
Prognostic significance of the sentinel lymph node (SLN) in stage I or II melanoma patients: 368 (1997) (6)
Developing a Value Framework: Utilizing Administrative Data to Assess an Enhanced Care Initiative. (2021) (6)
Expression and Clinical Significance of Protein Kinase RNA–Like Endoplasmic Reticulum Kinase and Phosphorylated Eukaryotic Initiation Factor 2&agr; in Pancreatic Ductal Adenocarcinoma (2019) (6)
Predicting the Presence of Parathyroid Carcinoma (2005) (6)
Perceptions of opioid use and prescribing habits in oncologic surgery: A survey of the society of surgical oncology membership (2020) (6)
Treatment related toxicities with rapid-fractionation external beam radiation therapy and concomitant gemcitabine for locally advanced nonmetastic adenocarcinoma of the pancreas (1998) (5)
Genetic characterization of medullary thyroid cancer in childhood survivors of the Chernobyl accident (2019) (5)
Laparoscopic Partial Splenectomy for Unknown Primary Cancer: A Stepwise Approach (2017) (5)
A PGC1β genetic variant associated with nevus count and melanoma mortality (2017) (5)
Characterization of novel neutralizing mouse monoclonal antibody JM1-24-3 developed against MUC18 in metastatic melanoma (2020) (5)
Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma (2018) (5)
Impact and Timing of Bilateral Adrenalectomy for Refractory ACTH-Dependent Cushing’s Syndrome (2013) (5)
Diagnostic imaging modalities for the surveillance of melanoma patients: A meta-analysis. (2010) (5)
Laparoscopic Insulinoma Enucleation from the Retro-Pancreatic Neck: A Stepwise Approach (2016) (5)
Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma (2022) (5)
Updated survival analysis of preoperative gemcitabine (gem) plus bevacizumab (bev)-based chemoradiation for resectable pancreatic adenocarcinoma. (2012) (5)
Considering Postoperative Functional Hypoaldosteronism after Unilateral Adrenalectomy (2017) (5)
Pancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic Adenocarcinoma (2018) (5)
Operative technique for single incision robot-assisted transaxillary thyroid surgery (2011) (5)
Impact of Surgical Resection for Subdiaphragmatic Paragangliomas (2014) (5)
Abstract 614: Resiquimod, a Toll-like receptor agonist promotes melanoma regression by enhancing plasmacytoid dendritic cells and T cytotoxic activity as a vaccination adjuvant and by direct tumor application (2018) (4)
Nodal Recurrence is a Primary Driver of Early Relapse for Patients with Sentinel Lymph Node-Positive Melanoma in the Modern Therapeutic Era (2021) (4)
Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma. (2020) (4)
4-Nitroquinoline-1-oxide-induced mutagen sensitivity and risk of cutaneous melanoma: a case–control analysis (2016) (4)
Early Experience of a Robotic Foregut Surgery Program at a Cancer Center: Video of Shared Steps in Robotic Pancreatoduodenectomy and Gastrectomy (2021) (4)
Iterative Changes in Risk-Stratified Pancreatectomy Clinical Pathways and Accelerated Discharge After Pancreaticoduodenectomy (2022) (4)
Erratum: Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-? (Journal of Investigative Dermatology (2015) 135 (2901) DOI:10.1038/jid.2015.259) (2015) (4)
Genetic variants in glutamine metabolic pathway genes predict cutaneous melanoma‐specific survival (2019) (4)
200 Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion Rates and Survival (2013) (4)
Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Identification of clinical targets for optimization. (2019) (4)
External Retraction Techniques for Robotic Pancreatoduodenectomy. (2020) (4)
Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival (2017) (3)
Nodal failure after lymphatic mapping (LM) and negative sentinel lymph node (SLN) biopsy in stage I or II melanoma patients: 101 (1997) (3)
A phase I/II study of lymphodepletion plus adoptive cell transfer (ACT) with T cells transduced with CXCR2 and NGFR followed by high dose interleukin-2 (IL-2) in patients with metastatic melanoma (MM). (2016) (3)
Relapse-free survial and target identification to enhance response with neoadjuvant and adjuvant dabrafenib + trametinib (D+T) treatment compared to standard-of-care (SOC) surgery in patients (pts) with high-risk resectable BRAF-mutant metastatic melanoma. (2017) (3)
Spleen and splenic vessel preserving distal pancreatectomy for bifocal PNET in a young patient with MEN1 (2016) (3)
3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma (2022) (3)
Cervical hematoma following an endocrine surgical procedure: The MD Anderson experience. (2016) (3)
Preoperative (Neoadjuvant) Therapy for Resectable Adenocarcinoma of the Pancreas (2002) (3)
Pathological diaphragmatic invasion by colorectal liver metastases is associated with RAS mutation, peritoneal recurrence and worse survival. (2018) (3)
Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therapy (2021) (3)
Standard Forms of Pancreatic Resection (1998) (3)
Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients with Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase I Trial and Imaging-based Biomarker Validation. (2022) (3)
Genetic variants in the integrin signaling pathway genes predict cutaneous melanoma survival (2017) (3)
Surgical Eligibility Does Not Imply Surgical Equity (2021) (3)
Middle Hepatic Vein Roadmap for a Safe Laparoscopic Right Hepatectomy (2018) (3)
Complex General Surgical Oncology Fellowship Applicants: Trends over Time and the Impact of Board Certification Eligibility (2019) (3)
Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival. (2021) (3)
Rapid assessment of technical competency: the 8-min suture test. (2016) (3)
Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma (2021) (3)
Multimodality therapy for adenocarcinoma of the pancreas: The M.D. Anderson experience (1997) (3)
Recurrence after successful parathyroidectomy-Who should we worry about? (2021) (3)
Total Laparoscopic Management for Stage IV Colorectal Cancer Requiring Multivisceral Resection (2017) (3)
Multiple Endocrine Neoplasia (2011) (3)
Abstract 5568: Elevated interleukin-12 is a plasma marker of poor prognosis in stage III melanoma patients (2008) (2)
Evaluation of Plasma Interleukin-6 in Melanoma Patients as a Prognostic and Checkpoint Immunotherapy Predictive Biomarker. (2021) (2)
Chemotherapy vs chemoradiation as preoperative therapy for resectable pancreatic ductal adenocarcinoma: a propensity score adjusted analysis (2018) (2)
Outcome of patients with adrenal metastasis from lung cancer: Selection criteria for surgery. (2010) (2)
Indocyanine green fluorescence counterstaining for anatomic laparoscopic partial splenectomy (2018) (2)
Preoperative chemoradiotherapy, pancreaticoduodenectomy, and external- beam intraoperative radiotherapy for pancreatic adenocarcinoma: The M.D. Anderson experience (1994) (2)
Impact of race on surgical management of pancreatic neuroendocrine tumors. (2016) (2)
Evaluation of Plasma IL-6 in Patients with Melanoma as a Prognostic and Checkpoint Immunotherapy Predictive Biomarker (2022) (2)
Endocrine incidentalomas. (2016) (2)
Dehisced corneal button with no evidence of a ruptured globe. (2013) (2)
Melanoma Expression Genes Identified through Genome-Wide Association Study of Breslow Tumor Thickness. (2017) (2)
Publisher Correction: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways (2019) (2)
Biomarker study in patients with resectable AJCC stage IIIc or stage IV (M1a) melanoma treated in a randomized phase II neoadjuvant trial. (2013) (2)
Pancreatic ductal adenocarcinoma: neoadjuvant therapies and pathology (2014) (2)
Association of genetic variants of TMEM135 and PEX5 in the peroxisome pathway with cutaneous melanoma-specific survival (2021) (2)
History of preoperative therapy for pancreatic cancer and the MD Anderson experience (2021) (2)
A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients (2022) (2)
Opioid Discharge Prescriptions After Inpatient Surgery: Risks of Rebound Refills by Length of Stay. (2022) (2)
Contemporary Assessment of Need for Palliative Bypass After Aborted Pancreatoduodenectomy Following Neoadjuvant Therapy (2022) (2)
Differences in Clinicopathologic Behavior of Oncocytic Adrenocortical Neoplasms and Conventional Adrenocortical Carcinomas (2022) (2)
Therapeutic Neck Dissection for Melanoma (2006) (2)
Association of Patient Controlled Analgesia and Total Inpatient Opioid Use After Pancreatectomy. (2022) (2)
Outcomes of Duodenal Stent vs. Gastrojejunostomy in Patients with Malignant Gastric Outlet Obstruction - Report from Tertiary Care Cancer Center: 1371 (2011) (1)
Abstract CT156: Novel neoadjuvant targeted therapy trial yields insight into molecular mechanisms of response (2017) (1)
All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients (2016) (1)
Hepatic Manifestations of Systemic Mastocytosis (SM): 810 (2010) (1)
Patterns of recurrence in 208 patients with Merkel cell carcinoma. (2010) (1)
Pancreatic neuroendocrine tumors and multiple endocrine neoplasia (2018) (1)
Do no harm, except to ourselves? Surgeons in the operating room, a meta-analysis of musculoskeletal symptoms and ergonomic interventions (2014) (1)
1062 Outcome of Referral to an Endoscopic Mucosal Resection Center As an Alternative to Surgery in Patients With Large and Flat Colon Tumors (2015) (1)
Comparative Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Manual for Adrenocortical Carcinoma (2020) (1)
735PThe prognostic significance of infiltrating lymphocytes in resectable pancreatic ductal adenocarcinoma in untreated versus neoadjuvant treated patients (2017) (1)
First line gemcitabine and nab-paclitaxel chemotherapy for localized pancreatic ductal adenocarcinoma. (2018) (1)
Genetic variants of EML1 and HIST1H4E in myeloid cell-related pathway genes independently predict cutaneous melanoma-specific survival. (2021) (1)
A Longitudinal Assessment of Anthropometric Changes in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Preoperative Therapy and Pancreatoduodenectomy (2017) (1)
Sa1471 When Patients Watch a Video, Physicians See More Adenomas: an Educational Bowel Preparation Video Improves Adenoma Detection RATES (2015) (1)
Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy (2023) (1)
Abstract 1547: Expression of epithelial-to-mesenchymal transition markers (EMT) in treated pancreatic duct adenocarcinoma (2018) (1)
Reply to Z. Li et al. (2015) (1)
Genetic variants in TKT and DERA in the nicotinamide adenine dinucleotide phosphate pathway predict melanoma survival. (2020) (1)
Survival in patients with synchronous versus metachronous lymph node (LN) involvement in stage III melanoma: Is there a difference? (2008) (1)
Long-Term Outcome of Mucinous Pancreatic Cystic Lesions in Cancer Survivors or Patients With Extra-Pancreatic Malignancy (2018) (1)
Loss of SMAD4 and effect on overall survival in resected gastrointestinal neuroendocrine tumors. (2014) (1)
Risk-stratified use of perioperative pasireotide does not decrease post-operative pancreatic fistula in high-risk pancreatectomy patients (2019) (1)
Sa1436 Are Prophylactic Antibiotics Necessary to Reduce the Risk of Post ERCP Related Infections in Cancer Patients (2017) (1)
Tips and tricks of splenic vessel preservation during laparoscopic distal pancreatectomy (2017) (1)
Radiographic and Serologic Response to First-Line Chemotherapy in Unresected Localized Pancreatic Cancer. (2022) (1)
Utilization and evolving prescribing practice of opioid and non‐opioid analgesics in patients undergoing lymphadenectomy for cutaneous malignancy (2021) (1)
ASO Author Reflections: Temporary Mesocaval Shunt: Indications and Technique for Safe Resection of Pancreatic Tumors With Mesenteric Venous Occlusion (2019) (1)
HLA class II alleles predict recurrence and pattern of failure in early-stage melanoma patients (2007) (1)
GRP78 expression and prognostic significance in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy versus surgery first. (2021) (1)
439 To Capture Complication-Related Readmission After Pancreatectomy “90-Days From Surgery” Is Superior to “30-Days From Discharge” (2015) (1)
Adenocarcinoma of the pancreas (1996) (1)
Long-term cure after complete resection and adjuvant immunotherapy for distant melanoma metastases (2012) (1)
Prognostic value of S100B levels and LDH levels in melanoma patients (2008) (1)
Novel genetic variants of PIP5K1C and MVB12B of the endosome-related pathway predict cutaneous melanoma-specific survival. (2020) (1)
Lymphodepletion (LD), tumor-infiltrating lymphocytes (TIL) and high (HD-IL2) versus low-dose (LD-IL2) IL-2 followed by pembrolizumab (pembro) in patients (pts) with metastatic melanoma (MM). (2019) (1)
Unusual functioning endocrine tumors (2004) (1)
Effect of dose-escalation of IMRT for unresectable pancreatic cancer 1 cm away from the luminal mucosa on long-term survival. (2015) (1)
Corrigendum to "Exonuclease 1 (EXO1) gene variation and melanoma risk" 11 (2012) 304-309 (2012) (1)
Role of surveillance CT scans in resected PC: Correlation with CA19-9 and symptoms. (2010) (1)
ASSOCIATION OF HLA-DQB1*0301 WITH MALIGNANT MELANOMA. AUTHOR'S REPLY (1996) (1)
Treatment of Non-alcoholic Fatty Liver Disease with the Carotenoid Zeaxanthin in a Quail Model: 361 (2009) (1)
Comparative analysis of opioid use between robotic and open pancreatoduodenectomy (2022) (1)
Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration of cystic lesions of the pancreas (2003) (1)
Vascular Resection for Pancreatic Cancer (2008) (1)
Technique for Robotic Pancreaticojejunostomy. (2022) (0)
639 ITERATIVE CHANGES IN RISK-STRATIFIED PANCREATECTOMY CLINICAL PATHWAYS AND FACTORS ASSOCIATED WITH ACCELERATED DISCHARGE AFTER PANCREATICODUODENECTOMY (2021) (0)
Androgen receptor activity promotes resistance to BRAF-targeted melanoma therapy (2020) (0)
Sa1705 – Characteristics and Endoscopic Management of Gastric Neuroendocrine Tumors (2019) (0)
Comparison of the Utility of Covered vs. Uncovered Metal Stents in the Management of Malignant Biliary Strictures in 749 Patients Presidential Poster: 227 (2012) (0)
Sa1109 Clinical Impact of EUS Exam in the Evaluation of Subepithelial Lesions of the Lower Gastrointestinal Tract (2015) (0)
309 IMPLEMENTATION OF AN AUTOMATED DATA ABSTRACTION WORKFLOW TO FACILITATE QUALITY IMPROVEMENT AND RESEARCH (2021) (0)
Mo1356 CHARACTERIZATION AND PREDICTORS OF DISEASE PROGRESSION IN PANCREATIC NEUROENDOCRINE TUMORS DIAGNOSED BY EUS-FNA. A 10-YEAR TERTIARY CARE CENTER EXPERIENCE (2018) (0)
Su1611 Outcome of a Protocol Driven Endoscopic Resection of Patients With Large Colon Polyps (>20 MM) Results in Low Complications and Recurrence (2017) (0)
Tu1251 Is Endoscopic Ultrasound More Accurate Than Computed Tomography in Esophageal Cancers Staging (2017) (0)
Long-term evaluation of patients (Pts) with malignant melanoma (MM) treated with autologous cancer vaccine HSPPC-96 at three different dose levels (2005) (0)
Surgical Management of Distant Melanoma Metastases (2019) (0)
Abstract 5527: Overexpression of protein phosphatase 4 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma (2012) (0)
Is Second Look for Staging of Newly Diagnosed Esophageal Cancer Necessary?: ACG/AstraZeneca Fellow Award: 1987 (2013) (0)
Sa1430 ENDOSCOPIC RADIO FREQUENCY ABLATION IN THE MANAGEMENT OF UNRESECTABLE HILAR AND DISTAL CHOLANGIOCARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS (2019) (0)
Su1723 EFFICACY OF SELF EXPANDABLE METAL STENTS IN EXTRINSIC MALIGNANT COLONIC OBSTRUCTION. A 10-YEAR TERTIARY CARE CENTER EXPERIENCE (2018) (0)
924 SAFETY OF ENDOSCOPIC PROCEDURES IN CANCER PATIENTS WITH NEUTROPENIA: FIVE YEARS CANCER CENTER EXPERIENCE (2018) (0)
Tu1494 Delayed Pancreatitis Risk With Chemoradiation After Metal Biliary Stent Placement for Malignant Biliary Obstruction (2017) (0)
Early postoperative drain fluid amylase in risk-stratified patients: Implications for tailored post-pancreatectomy drain management (2019) (0)
Reply to: Genotype-Phenotype Pancreatic Neuroendocrine Tumor Relationship in Multiple Endocrine Neoplasia Type 1 Patients: A 23 Year Experience at a Single Institution. (2018) (0)
Mo1503 – Comparison of Self-Expanding Metal Stents in Malignant Biliary Obstruction: Then and Now – a Tertiary Cancer Center Experience (2019) (0)
Do patient-reported quality-of-life responses in melanoma patients vary by stage? (2014) (0)
Sa1223 Pancreatic Cancer Screening (PCS) in High Risk Individuals (HRI) With Genetic Mutations (2016) (0)
Mo1265 Echosonographic Characteristics of Regional Lymph Nodes Are Predictive of Malignant Spread in Esophageal Cancer (2017) (0)
Reliability and validity of the Functional Assessment of Cancer Therapy-melanoma (FACT-M) (2007) (0)
ID: 3523057 ACUTE PANCREATITIS AFTER ENDOSCOPIC ULTRASOUND GUIDED SAMPLING OF PANCREATIC LESIONS (2021) (0)
Effects of a Pragmatic Home-based Exercise Program Concurrent with Neoadjuvant Therapy on Physical Function of Patients with Pancreatic Cancer: The Pancfit Randomized Clinical Trial. (2023) (0)
Use of operability classifications to predict outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy. (2012) (0)
ID: 3524590 EXPLORING THE ROLE OF ENDOSCOPIC FULL THICKNESS RESECTION AT AN ACADEMIC TERTIARY CARE CANCER CENTER SETTING (2021) (0)
Recurrent parathyroid carcinoma and the need for molecular profiling to aid in prognostication and therapeutics. (2015) (0)
Glycogenic Hepatopathy: A Rare but Reversible Cause of Diabetic Liver Disease: 777 (2011) (0)
Positive cystic duct stump at index cholecystectomy in incidental gallbladder cancer is a strong negative prognosticator even in patients without residual disease at oncologic re-resection (2018) (0)
Incidence and Impact of a Close Superior Mesenteric Artery Margin Following Pancreaticoduodenectomy for Adenocarcinoma (2011) (0)
Oncocytic Adrenal Tumors: A 43 Case Series of This Rare Variant (2018) (0)
Impact of race and socioeconomic factors on surgical management of pancreatic neuroendocrine tumors (2017) (0)
Mo1264 Does the Accuracy of Regional Lymph Node Staging Vary Between Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma (2017) (0)
Improved superior mesenteric artery exposure and reduced blood loss risk using temporary mesocaval shunt for locally advanced pancreatic cancer (2018) (0)
Tu1023 Malignant Intrahepatic Biliary Obstructions: Do Antibiotics Prevent Cholangitis in Patients With Incomplete Biliary Drainage? (2017) (0)
Incidence of Postoperative Complications Following Pancreatectomy for Pancreatic Cystic Lesions or Pancreatic Cancer (2022) (0)
709 The Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined to and Extending Beyond the Pancreas (2016) (0)
Nitric oxide (NO), neopterin, and cytokine levels versus clinical response in stage III melanoma patients receiving concurrent biochemotherapy: 390 (1997) (0)
Obesity does not Affect Adverse Event Risk following Percutaneous Endoscopic Gastrostomy Tube Placement (2017) (0)
Parathyroidectomy for elderly patients is safe (2008) (0)
Laparoscopic glissonean pedicle transection method (TAKASAKI) for negative fluorescent counterstaining of segment 6 (2017) (0)
Tu1148 ENDOSCOPIC MUCOSAL RESECTION AND RADIOFREQUENCY ABLATION ARE SAFE AND EFFECTIVE IN CURATIVE TREATMENT OF EARLY ESOPHAGEAL ADENOCARCINOMA (2018) (0)
Predictive Biomarkers and Personalized Medicine Speci fi c Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-In fi ltrating Lymphocytes in Metastatic Melanoma Patients (2012) (0)
Tu1643 A Prospective Comparison Study of a Standard 25-Gauge Needle With a 22-Gauge Core Needle Using Standard Suction and Capillary Suction Technique for Cytologic and Histologic EUS-Guided Sampling of Solid Pancreatic Lesions (2015) (0)
Mo1322 THE DIAGNOSTIC VALUE OF EUS-FNA AND OUTCOMES IN PATIENTS WITH RARE PANCREATIC MALIGNANCIES. A 10-YEAR TERTIARY CARE CENTER EXPERIENCE (2018) (0)
Mo1215 Does Poor Abdominal Wall Transillumination Predict Failed Placement of Percutaneous Endoscopic Gastrostomy Tubes (2017) (0)
908 Laparoscopic Insulinoma Enucleation From the Retro-Pancreatic Neck: A Stepwise Approach (2016) (0)
The Impact of Adjuvant Therapy Delay on Survival Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma (2017) (0)
Su1346 - The Characteristics, Pathologic Predictors of Recurrence, and Utility of Surgical Resection of Solid Pseudopapillary Neoplasms: A 20 Year Experience at a Tertiary Cancer Center (2018) (0)
417 Role of Preoperative 5-Fluorouracil, Doxorubicin and Streptozotocin Therapy in the Treatment of Localized Pancreatic Neuroendocrine Tumors (2016) (0)
Esophageal Fibrovascular Polyp Presenting as an Esophageal Mass: 1612 (2016) (0)
ASO Author Reflections: Accelerating the Learning Curve of Robotic Pancreatectomy and Gastrectomy Through a Composite Robotic Foregut Surgical Oncology Program (2021) (0)
Mo1325 DIAGNOSTIC VALUE OF EUS-FNA FOR METASTATIC LESIONS TO THE PANCREAS. A 10-YEAR TERTIARY CARE CENTER EXPERIENCE (2018) (0)
Prolonged Endoloop Ligation is Safe and Effective in the Management of Colonic Lipoma: 1329 (2012) (0)
Tu1027 Better Management of Patients With Large Colon Polyps Requires Improvement in the Knowledge Gaps Among Referring Endoscopists (2017) (0)
Su1163 ENDOSCOPIC ULTRASOUND GUIDED TISSUE ACQUISITION FOR GASTRIC CANCER DIAGNOSTIC PROFILING AS AN ADJUNCT TO ENDOSCOPIC MUCOSAL BIOPSIES (2019) (0)
Ninety-day Postoperative Mortality Is a Legitimate Measure iliary Surgical Quality of Hepatopancreatob (2015) (0)
Tu1020 A Pragmatic Evaluation of Targets Set by the American Society for Gastrointestinal Endoscopy for ERCP Priority Quality Indicators in a Cancer Population (2017) (0)
Tu1467 Post ERCP Cholecystitis After Metal Biliary Stent Placement: Do Proximal Malignant Biliary Strictures Increase the Risk? (2017) (0)
Inverse-probability weighted and propensity score-based analysis of long-term clinical outcomes comparing 3D conformal radiotherapy (3DCRT) with intensity-modulated radiation therapy (IMRT) in the treatment of esophageal cancer. (2012) (0)
Does Prior Abdominal Surgery Increase the Incidence of Adverse Events following Percutaneous Endoscopic Gastrostomy Tube Placement (2017) (0)
Oncologic outcomes of preoperative therapy for distal cholangiocarcinoma (2018) (0)
Evaluating the Role of EUS-FNA in the Diagnosis of Metastasis to the Pancreas: Results From a Tertiary Cancer Center: 305 (2014) (0)
The Efficacy of ERCP and PTBD and Comparison of Survival in Unilateral Versus Bilateral Drainage in Patients With Cholangiocarcinoma: Experience From a Single Tertiary Cancer Specialty Institute: 306 (2014) (0)
861 A Standardized Radiographic Assessment of the Tumor-Vein Interface Predicts the Need for Venous Resection and the Presence of Histologic Venous Invasion in Borderline Resectable Pancreatic Cancer (2013) (0)
Sa1090 Management of Non-Ampullary Duodenal Adenomas in Patients With Familial Adenomatous Polyposis (FAP) and Non-FAP Patients: Should We Manage Them Differently? (2015) (0)
Genetic variants of SDCCAG8 and MAGI2 in mitosis‐related pathway genes are independent predictors of cutaneous melanoma‐specific survival (2021) (0)
Su1375 OUTCOMES OF ENDOSCOPIC RESECTION OF NON-AMPULLARY DUODENAL ADENOMAS: A TERTIARY CANCER CENTER EXPERIENCE (2019) (0)
Tu1427 Does Chemoradiation Increase Ascending Cholangitis Risk After Metal Biliary Stent Placement for Malignant Biliary Obstruction (2017) (0)
1052 ONCOLOGIC OUTCOMES OF CYST-ASSOCIATED VS. CLASSICAL PANCREATIC DUCTAL ADENOCARCINOMA (2020) (0)
Multiple Endocrine Neoplasia (MEN1) Patients Need Close Monitoring and Aggressive Management (2015) (0)
Variation in and predictors of inpatient opioid utilization after pancreatectomy (2018) (0)
Role of ERCP in Evaluation of Post-stem Cell Transplantation Patients with Hepatobiliary Disease: 143 (2010) (0)
Tu1410 Does Chemoradiation Prevent Recurrent Biliary Obstruction Following Metal Biliary Stent Placement (2017) (0)
211 Genetic variants in the Wnt pathway genes NFATC1 and PLCB1 predict melanoma survival (2016) (0)
Polymorphisms of Fas and the Fas ligand increase the risk of cutaneous malignant melanoma (2006) (0)
Su1484 Clear Bile (CB) and Dark Bile (DB) in Malignant Biliary Obstruction With Naïve Papilla: Does It Affect Survival? (2016) (0)
670 - Peakbil >7 Mg/Dl Classification of Post-Hepatectomy Liver Failure is a Predictor of Poor Oncologic Outcome in Patients Undergoing Hepatectomy for Colorectal Liver Metastases (2018) (0)
Re-Resection of a Positive Pancreatic Margin is Associated with Prolonged Survival Among Patients with Pancreatic Cancer Treated with Preoperative Therapy and Pancreatoduodenectomy (2017) (0)
Su1462 – Pancreatic Duct Caliber Does Not Reliably Distinguish Malignant from Premalignant Main Duct Ipmns (2019) (0)
Su1462 – Pancreatic Duct Caliber Does Not Reliably Distinguish Malignant from Premalignant Main Duct Ipmns (2019) (0)
Contemporay assessment of extrahepatic bile duct strictures (2003) (0)
TITLE : BAP 1 loss of function promotes liver tropism of uveal melanoma cells in vivo (2016) (0)
Resection of the Superior Mesenteric-Portal Vein Confluence During Pancreaticoduodenectomy (1997) (0)
From scalpel to console (2010) (0)
QS263. Incidence of Follicular Thyroid Carcinoma: A 17 Year Experience of Pre-Operative Fine Needle Aspiration Classification As Follicular Lesion Versus Follicular Neoplasm (2008) (0)
Hidden Menace: Transitional Cell Cancer with Duodenal Mucosal and Lacteal Vascular Metastases: 688 (2011) (0)
8-Minute Suture Skills Test Predicts Clinical Technical Performance in Advanced Trainees (2013) (0)
Variable Selection with False Discovery Control (2015) (0)
Neuroendocrine Tumors of Gastrointestinal Tract and the Pancreas: Diagnostic Modalities, Accuracy, and Outcomes: 246 (2009) (0)
Tu1441 Does Sphincterotomy Reduce Post-ERCP Pancreatitis Risk After Covered Metal Biliary Stent Placement for Malignant Biliary Obstruction? (2017) (0)
Sa1704 – Endoscopic Management of Duodenal Neuroendocrine Tumors (2019) (0)
Sa1295 ENDOSCOPIC MANAGEMENT AND OUTCOMES OF AMPULLARY LESIONS. A 5-YEAR TERTIARY CARE CENTER EXPERIENCE (2018) (0)
Impact of perioperative blood transfusions on survival in patients with borderline resectable pancreatic adenocarcinoma after neoadjuvant therapy (2018) (0)
Secreted alkaline phosphatase defined by ms17-57 mab and ectopically expressed on the surface of GI cancer cells as a potential therapeutic target. (2013) (0)
SY-4-KL Borderline resectable pancreatic cancer : Questions and controversies (2014) (0)
Su1257 – Characteristics of Gastrointestinal Stromal Tumors Using Endoscopic Ultrasound (2019) (0)
Diagnosis, Antibiotic Prophylaxis, and Natural History of Pancreatic Cystic Neoplasms: Is Immediate Surgery Necessary? (2008) (0)
Su1125 – Esophageal Stent Placement for Post-Operative Complications in Patients with Esophageal Surgery Secondary to Malignancy (2019) (0)
846 - T2B Incidental Gallbladder Cancer Patients Derive a Negative Impact on Survival from Index Cholecystectomy (2018) (0)
Recurrence Patterns and Survival Outcomes after Multidisciplinary Treatment of Pancreatic Cancer (2022) (0)
534 SAFETY OF ENDOSCOPIC PROCEDURES IN CANCER PATIENTS WITH THROMBOCYTOPENIA: A TERTIARY CARE CANCER CENTER EXPERIENCE (2018) (0)
ID: 3526615 EFFICACY AND SAFETY OF ENDOSCOPIC FIXATION TO PREVENT MIGRATION OF ESOPHAGEAL STENTS. A TERTIARY CARE CENTER EXPERIENCE (2021) (0)
The impact of tumor differentiation on perioperative outcomes and patterns of recurrence following preoperative therapy for resectable pancreatic adenocarcinoma (2018) (0)
Su1500 Safety of Endoscopic Ultrasound Guided Fine Needle Aspiration (EUS-FNA) of Lower Gastrointestinal Tract (2015) (0)
Prognostic value of biomarkers in tissue microarrays (TMAs) of squamous cell carcinomas of the oral tongue (SCCOT). (2010) (0)
Sa1468 ROLE OF ARGON PLASMA COAGULATION IN THE SETTING OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (2019) (0)
Abstract 1344: IL-6 blood level represents an independent biomarker of melanoma patient prognosis (2019) (0)
[Frontiers in Bioscience 3, e194-204, November 1, 1998] 194 NEOADJUVANT CHEMORADIATION FOR ADENOCARCINOMA OF THE PANCREAS (1998) (0)
Impact of first-day intravenous patient controlled analgesia use on total inpatient opioid use after pancreatectomy (2018) (0)
ID: 3523951 METAL BILIARY STENTS FOR BILIARY OBSTRUCTION IN CHOLANGIOCARCINOMA (2021) (0)
In Brief. (2016) (0)
Melanophages in the Rectum, Not Melanoma!: 1251 (2008) (0)
Russell Body Duodenitis: 612 (2010) (0)
Mo1282 LONG-TERM OUTCOMES IN PATIENTS WHO UNDERWENT SURGERY AFTER EUS-FNA DIAGNOSIS OF NEOPLASTIC SOLID PANCREATIC LESIONS (NSPL). A 5-YEAR TERTIARY CARE CENTER EXPERIENCE (2018) (0)
Reducing cost of hospitalization with risk stratified post-pancreatectomy clinical pathways at a single high-volume institution (2018) (0)
Tu1199 COMPARISON OF THE SUCCESS OF ENDOSCOPIC TREATMENT IN EARLY ESOPHAGEAL SQUAMOUS CELL CANCER AND ESOPHAGEAL ADENOCARCINOMA. A NINE YEARS EXPERIENCE FROM A CANCER HOSPITAL (2018) (0)
Low volume institutions are associated with delay and omission of adjuvant chemotherapy for resected pancreatic adenocarcinoma independent of surgical approach (2017) (0)
ID: 3526877 ENDOSCOPIC ULTRASOUNG-GUIDED PORTAL VEIN SAMPLING OF CIRCULATING TUMOR CELLS IN PANCREATIC ADENOCARCINOMA – A PROSPECTIVE RANDOMIZED PILOT STUDY COMPARING A 22 AND 19-GAUGE (G) NEEDLE (2021) (0)
Sa1546 Outcome of Management of Colon Polyps Larger Than 20 mm At a Referral Endoscopic Mucosal Resection Center (2015) (0)
Su1475 Outcomes of Stent-in-Stent (SIS) in the Management of Malignant Distal Biliary Obstruction (MDBO) (2016) (0)
Loss of muscle mass during preoperative chemotherapy predicts worse recurrence-free survival in patients with resectable colorectal liver metastases (2018) (0)
Tu1958 Characterization of Pancreatic Abnormalities and Detection During Pancreatic Cancer (PC) Screening of High Risk Individuals (HRI) (2015) (0)
The Diagnostic Yield of Imaging Modalities in Screening for Pancreatic Cancer in Asymptomatic High-Risk Individuals: Experience From a Tertiary Cancer Center: 326 (2014) (0)
Abstract LB-335: Associations of functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma risk (2012) (0)
Cost-effectiveness of neoadjuvant (NeoAdj) versus adjuvant (Adj) therapies for resectable pancreatic cancer (PC). (2010) (0)
Rapid Onset of Massive Hepatomegaly in a Young Patient: 792 (2010) (0)
Contemporary Analysis of Complications Associated with Biliary Stents During Neoadjuvant Therapy for Pancreatic Adenocarcinoma (2017) (0)
Esophageal Squamous Papilloma: a Rare Incidental Finding on Upper Gastrointestinal Endoscopy: 487 (2011) (0)
Predictive Biomarkers and Personalized Medicine Impact of Clinical and Pathologic Features on Tumor-Infiltrating Lymphocyte Expansion from Surgically Excised Melanoma Metastases for Adoptive T-cell Therapy (2011) (0)
Sa1084 Endoscopic Mucosal Resection (EMR) of Nonampullary Duodenal Polyps With or Without EMR-Cap (2015) (0)
997 Laparoscopic Strong Procedure for Wilkie Syndrome (Complete Intestinal Derotation for SMA Syndrome) (2015) (0)
Combined modality therapy for patients with nodal metastases from melanoma (2005) (0)
ASO Visual Abstract: Differences in the Clinicopathologic Behavior of Oncocytic Adrenocortical Neoplasms and Conventional Adrenocortical Carcinomas (2022) (0)
Venous Shunting Procedures for Borderline Resectable Pancreatic Cancer (2016) (0)
Accelerated liver hypertrophy is associated with recurrence in patients with colorectal liver metastases (2018) (0)
Mo1204 The Effect of Prophylactic Antibiotic Timing on Peristomal Cellulitis Following Percutaneous Endoscopic Gastrostomy Tube Placement (2017) (0)
Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer (2022) (0)
Positive cystic duct at index-cholecystectomy is an important negative prognosticator in incidental gallbladder cancer even if no residual cancer is found at oncologic extended resection (2018) (0)
AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatment sequencing (2021) (0)
Reviewing the Review: Assessment of the Peer-Review Process in Surgical Journals (2017) (0)
The impact of physician specialty on quality of melanoma care. (2010) (0)
Su1170 EUS-GUIDED BILIARY DRAINAGE AFTER FAILED ERCP: A TERTIARY CANCER CENTER EXPERIENCE (2019) (0)
2264 Metastatic gastroesophageal adenocarcinoma patients treated with systemic therapy followed by local therapy: A nomogram associated with long-term survivors (2015) (0)
Abstracts reprinted from Journal of Clinical Oncology (2007) (0)
Tu1434 THE SINGLE SESSION: FEASIBILITY AND OUTCOMES OF COMBINED EUS-FNA AND ERCP PROCEDURES. A 5-YEAR TERTIARY CARE CENTER EXPERIENCE (2018) (0)
Pancreaticoduodenectomy for suspected cancer: Can patients with benign histopathology be identified prior to surgery? (2003) (0)
Tu2027 Endoscopic Versus Percutaneous Drainage for Management of Hilar Cholangiocarcinoma (2015) (0)
1 NEITHER SURGICAL MARGIN STATUS NOR SOMATIC MUTATION PREDICTS LOCAL RECURRENCE AFTER R0-INTENT RESECTION FOR COLORECTAL LIVER METASTASES (2021) (0)
722 – Identification of Sentinel Lymph Node Using Submucosal Injection of Indocyanine Green and Davinci Firefly Camera System (2019) (0)
Seventh Americas Hepatopancreatobiliary Congress ANNUAL SCIENTIFIC SESSION & POST GRADUATE PROGRAM April 19-22, 2007 Bally's Hotel Las Vegas, Nevada. (2007) (0)
Primary Colonic Leiomyosarcoma: 878 (2010) (0)
Su1463 – Natural History of Disease Progression and Interventions After Aborted Pancreatoduodenectomy for Pancreatic Adenocarcinoma (2019) (0)
2254 Initial standardized uptake value (iSUV) of positron emission tomography (PET) influences prognosis of patients with localized gastric adenocarcinoma treated preoperatively (2015) (0)
Sa1131 Comparison of Gastrojejunostomy and Enteral SEMS in Management of Malignant Gastric Outlet Obstruction- A Single Tertiary Care Cancer Center Experience (2013) (0)
419 - Are SEMS (Self-Expanding Metal Stents) a Safe and Successful Bridge to Surgery or Definitive Therapy for Malignant Colorectal Obstruction (MCO), Particularly in Patients Treated with Bevacizumab, a VEGF Inhibitor? A Tertiary Cancer Center Experience (2018) (0)
7009 Endoscopic ultrasound guided fine needle aspiration of solid pancreatic lesions: one year md anderson cancer center experience. (2000) (0)
Tu1402 COMPARISON OF THE PERFORMANCE OF COVERED METAL STENTS AND UNCOVERED METAL STENTS IN THE MANAGEMENT OF MALIGNANT BILIARY STRICTURES (MBO) IN 1012 PATIENTS. (2018) (0)
Obesity-related genetic variants, human pigmentation, and risk of melanoma (2013) (0)
Genomic HLA-DQB1 *0301 status predicts survival in stage I or II melanoma patients: 487 (1997) (0)
Incidence of Lymph Node Metastases and Impact of Radical Surgery for Duodenal Neuroendocrine Tumors. (2021) (0)
Walz Aldosteronoma (2007) (0)
925 Incremental Value of Endoscopic Ultrasound in Detecting Pancreatic Lesions in Patients With MEN1 (2019) (0)
Abstract 2961: Targeting stromal-derived Dickkopf-3 (DKK3) for the treatment of pancreatic ductal adenocarcinoma (PDAC) (2017) (0)
18 Results of biochemotherapy in the treatment of advanced melanoma,The M.D. Anderson Cancer Center Experience (1997) (0)
Mo1266 Does Histologic Grade of Esophageal Cancer Impact the Accuracy of Diagnostic Staging Modalities (2017) (0)
Tu1696 – Neutropenic Colitis - Clinical Features, Treatment and Outcomes (2019) (0)
Correction: Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma (2022) (0)
Pheochromocytoma recurrence in hereditary disease: does a cortical-sparing technique increase recurrence rate? (2022) (0)
778 Morbidity and Mortality After Pancreaticoduodenectomy in Patients With Borderline Resectable Type C Clinical Classification (2013) (0)
Surgical management of hereditary pheochromocytoma: Invited commentary (2004) (0)
Sa670 INCIDENCE OF POSTOPERATIVE COMPLICATIONS FOLLOWING RESECTION FOR MUCINOUS CYSTIC LESIONS VERSUS PANCREATIC DUCTAL ADENOCARCINOMA (2021) (0)
Tu1447 – Efficacy of Lumen-Apposing Metal Stent Insertion in Patients with Malignant Pancreatic Fluid Collections: A Tertiary Cancer Center Experience (2019) (0)
Imaging Characteristics, Role of EUS-FNA and Prognosis in Patients With Pancreatic Lymphoma: 210 (2014) (0)
Sa1410 Reporting Adenoma Detection Rate Confidence Intervals Provide Better Feedback About Endoscopists' Performance (2015) (0)
418 Evolution of Outcomes of Patients With Pancreatic Ductal Adenocarcinoma Undergoing Pancreatoduodenectomy Following Preoperative Therapy (2016) (0)
Feasibility of intraoperative CTC detection from portal vein during resection for pancreatic adenocarcinoma (2019) (0)
Treatment with neoadjuvant BRAF Inhibition Yields Responses in Patients (pts) with High Risk Borderline Resectable Stage III Melanoma. (2015) (0)
389 – Anatomic Resection of Colorectal Liver Metastases Does Not Improve Outcomes Over Non-Anatomic Resection Regardless of Ras Mutation Status (2019) (0)
Su1384 MANAGEMENT OF AMPULLARY LESIONS: 16 YEARS OF EXPERIENCE FROM A TERTIARY CANCER CENTER (2019) (0)
ID: 3523078 ENDOSCOPIC ULTRASOUND CHARACTERISTICS OF PANCREATIC NEUROENDOCRINE TUMORS (2021) (0)
Reviewing the review: a qualitative assessment of the peer review process in surgical journals (2018) (0)
Tu1474 – Utility of Endoscopic Ultrasound in the Diagnosis of Cholangiocarcinoma (2019) (0)
Differential Gains in Surgical Outcomes for High-Risk vs Low-Risk Pancreatoduodenectomy with Successive Refinements of Risk-Stratified Care Pathways. (2023) (0)
Su1384 MANAGEMENT OF AMPULLARY LESIONS: 16 YEARS OF EXPERIENCE FROM A TERTIARY CANCER CENTER (2019) (0)
LB958 Genetic variants in mTOR pathway genes DEPTOR and RPTOR predict melanoma survival (2017) (0)
Tumor interface stability on CT imaging is an early marker of response to cytotoxic therapy in pancreatic ductal adenocarcinoma. (2017) (0)
Accuracy of the Quantitative Fecal Immunochemical Test (FIT) for Colorectal Cancer and Advanced Adenoma Detection: An Updated Systematic Review and Meta-Analysis: Presidential Poster Award (2018) (0)
Comparison of Imaging Characteristics of CT, MRI, PET, and EUS in the Evaluation of Metastasis to the Pancreas: Results From a Single Tertiary Cancer Center: 280 (2014) (0)
Mo1270 Esophageal Cancer Regional Lymph Node Staging: Endoscopic Ultrasound Versus Positron Emission Tomography; Which Is Better? (2017) (0)
Is It Safe to Follow Cystic Pancreatic Neoplasms if Immediate Surgery Is Not Undertaken?: 169 (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jeffrey Edwin Lee?

Jeffrey Edwin Lee is affiliated with the following schools:

MD Anderson Cancer Center
Université Laval

Jeffrey Edwin Lee's Academic­Influence.com Rankings

Why Is Jeffrey Edwin Lee Influential?

Jeffrey Edwin Lee's Published Works

Published Works

What Schools Are Affiliated With Jeffrey Edwin Lee?

Jeffrey Edwin Lee's AcademicInfluence.com Rankings